Evidence-Based Medicine Guidelines
Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver
Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Hepatic Artery Adjuvant Chemotherapy for Patients Having Resection or Ablation of Colorectal Cancer Metastatic to the Liver." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450664/all/Hepatic_artery_adjuvant_chemotherapy_for_patients_having_resection_or_ablation_of_colorectal_cancer_metastatic_to_the_liver.
Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450664/all/Hepatic_artery_adjuvant_chemotherapy_for_patients_having_resection_or_ablation_of_colorectal_cancer_metastatic_to_the_liver. Accessed October 22, 2020.
Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. Retrieved October 22, 2020, from https://evidence.unboundmedicine.com/evidence/view/EBMG/450664/all/Hepatic_artery_adjuvant_chemotherapy_for_patients_having_resection_or_ablation_of_colorectal_cancer_metastatic_to_the_liver
Hepatic Artery Adjuvant Chemotherapy for Patients Having Resection or Ablation of Colorectal Cancer Metastatic to the Liver [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2020 October 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450664/all/Hepatic_artery_adjuvant_chemotherapy_for_patients_having_resection_or_ablation_of_colorectal_cancer_metastatic_to_the_liver.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver
ID - 450664
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450664/all/Hepatic_artery_adjuvant_chemotherapy_for_patients_having_resection_or_ablation_of_colorectal_cancer_metastatic_to_the_liver
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
